BIO AMOVIR SAS 179 rue du Poirier 14650 CARPIQUET FRANCE Capital Social : 2 000 000 € - Siret: 812 245 728 00017 ©2020 par BIO AMOVIR SAS. contact: contact@bioamovir.com
Benefits of rapid antigen tests
ANTIGEN TESTS
The SARS-CoV-2 Test Kits distributed by BIO AMOVIR is a chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigen in human nasal/nasopharyngeal/oropharyngeal samples and saliva. The identification is based on the specific monoclonal antibodies of the SARS-COV-2 nucleocapsid protein. The test confirms in 15 to 20 minutes the presence or absence of the SARS-CoV-2 antigen. The test provided only a preliminary test result, therefore, any results with the SARS-CoV-2 test kit should be confirmed with alternative test methods and clinical results.
Easy to use Early detection High sensitivity and specificity Result in 15 to 20 min without additional specific equipment
Clinical data
Compliance
The SARS-CoV-2 Test Kits distributed by BIO AMOVIR are CE conform and have a Confirmation of EU product notifications Prior to distribution in the following countries, we ensure that the tests are included in the lists of tests authorised by the health authorities. France Germany Spain Italy Belgium Portugal Brasil
Logistic Data
Prices 12/04/2021
BIO AMOVIR SAS 179 rue du Poirier 14650 CARPIQUET FRANCE Capital Social : 2 000 000 € Siret: 812 245 728 00017 contact: contact@bioamovir.com ©2020 par BIO AMOVIR SAS.
ANTIGEN TESTS
Benefits of rapid antigen tests
The SARS-CoV-2 Test Kits distributed by BIO AMOVIR is a chromatographic immunoassay for the qualitative detection of SARS-CoV-2 antigen in human nasal/nasopharyngeal/oropharyngeal samples and saliva. The identification is based on the specific monoclonal antibodies of the SARS- COV-2 nucleocapsid protein. The test confirms in 15 to 20 minutes the presence or absence of the SARS-CoV-2 antigen. The test provided only a preliminary test result, therefore, any results with the SARS-CoV-2 test kit should be confirmed with alternative test methods and clinical results.
Easy to use Early detection High sensitivity and specificity Result in 15 to 20 min without additional specific equipment
Clinical data
Compliance
The SARS-CoV-2 Test Kits distributed by BIO AMOVIR are CE conform and have a Confirmation of EU product notifications. Prior to distribution in the following countries, we ensure that the tests are included in the lists of tests authorised by the health authorities. France Germany Spain Italy Belgium Portugal Brasil
Logistic Data
Prices 12/04/2021